FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1861119325> ?p ?o ?g. }

• W1861119325 endingPage "3115" @default.
• W1861119325 startingPage "3107" @default.
• W1861119325 abstract "Objectives Initiation of empirical antifungal therapy for invasive candidiasis (IC) is usually based on clinical suspicion. Serological biomarkers have not yet been studied as a means of ruling out IC. We evaluated the potential role of two combined biomarkers in stopping unnecessary antifungals in patients at risk of IC in the ICU and in other wards. Methods This was a prospective observational study including adults starting empirical antifungal treatment for suspected IC, at Gregorio Maranon Hospital, Madrid (Spain). Patients were stratified according to admission department (ICU or other wards) and final diagnosis (no IC or proven or probable IC). Type of candidiasis (candidaemia or deep-seated candidiasis) was also considered. The Candida albicans germ tube antibody (CAGTA) test and the β-d-glucan (BDG) test were performed on serum samples collected by venepuncture on days 0, 3 and 5 after starting empirical antifungal therapy. Results Sixty-three ICU patients and 37 non-ICU patients were included. High-risk gastrointestinal surgery and sepsis in non-surgical patients were the main indications for empirical treatment (30% each). Patients had no IC (58%), proven IC (30%) or probable IC (12%). Overall, sensitivity and negative predictive value of the combination of both the CAGTA test and the BDG test were 97% for the entire population. The best performance was observed in ICU patients (sensitivity and negative predictive value of 100%). Among patients without IC, all biomarkers were negative in 31 patients. Conclusions Serial determination of CAGTA/BDG during empirical antifungal therapy has a high sensitivity and negative predictive value. If properly confirmed, this strategy could be used to discontinue antifungal treatment in at least 31% of patients as a complementary tool in antifungal stewardship programmes." @default.
• W1861119325 created "2016-06-24" @default.
• W1861119325 creator A5050159426 @default.
• W1861119325 creator A5071487615 @default.
• W1861119325 creator A5075222232 @default.
• W1861119325 creator A5075620145 @default.
• W1861119325 creator A5089446826 @default.
• W1861119325 date "2015-08-25" @default.
• W1861119325 modified "2023-10-10" @default.
• W1861119325 title "Combination of<i>Candida</i>biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment" @default.
• W1861119325 cites W1582970373 @default.
• W1861119325 cites W1886132783 @default.
• W1861119325 cites W1925232005 @default.
• W1861119325 cites W1965625796 @default.
• W1861119325 cites W1966837752 @default.
• W1861119325 cites W1981057885 @default.
• W1861119325 cites W1981262984 @default.
• W1861119325 cites W1988059036 @default.
• W1861119325 cites W1988769774 @default.
• W1861119325 cites W1995153426 @default.
• W1861119325 cites W1999505707 @default.
• W1861119325 cites W2011821883 @default.
• W1861119325 cites W2033288552 @default.
• W1861119325 cites W2047527295 @default.
• W1861119325 cites W2054190731 @default.
• W1861119325 cites W2065620879 @default.
• W1861119325 cites W2067529400 @default.
• W1861119325 cites W2069094767 @default.
• W1861119325 cites W2077307323 @default.
• W1861119325 cites W2085708157 @default.
• W1861119325 cites W2093270226 @default.
• W1861119325 cites W2096077989 @default.
• W1861119325 cites W2098156485 @default.
• W1861119325 cites W2104939875 @default.
• W1861119325 cites W2113002556 @default.
• W1861119325 cites W2114477653 @default.
• W1861119325 cites W2115921930 @default.
• W1861119325 cites W2129823146 @default.
• W1861119325 cites W2136218127 @default.
• W1861119325 cites W2137575148 @default.
• W1861119325 cites W2147659488 @default.
• W1861119325 cites W2150428940 @default.
• W1861119325 cites W2152509995 @default.
• W1861119325 cites W2161019652 @default.
• W1861119325 cites W2163845781 @default.
• W1861119325 cites W2166734004 @default.
• W1861119325 cites W2167026980 @default.
• W1861119325 cites W2170063898 @default.
• W1861119325 cites W2322839310 @default.
• W1861119325 cites W92562642 @default.
• W1861119325 doi "https://doi.org/10.1093/jac/dkv241" @default.
• W1861119325 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27272724" @default.
• W1861119325 hasPublicationYear "2015" @default.
• W1861119325 type Work @default.
• W1861119325 sameAs 1861119325 @default.
• W1861119325 citedByCount "53" @default.
• W1861119325 countsByYear W18611193252016 @default.
• W1861119325 countsByYear W18611193252017 @default.
• W1861119325 countsByYear W18611193252018 @default.
• W1861119325 countsByYear W18611193252019 @default.
• W1861119325 countsByYear W18611193252020 @default.
• W1861119325 countsByYear W18611193252021 @default.
• W1861119325 countsByYear W18611193252022 @default.
• W1861119325 countsByYear W18611193252023 @default.
• W1861119325 crossrefType "journal-article" @default.
• W1861119325 hasAuthorship W1861119325A5050159426 @default.
• W1861119325 hasAuthorship W1861119325A5071487615 @default.
• W1861119325 hasAuthorship W1861119325A5075222232 @default.
• W1861119325 hasAuthorship W1861119325A5075620145 @default.
• W1861119325 hasAuthorship W1861119325A5089446826 @default.
• W1861119325 hasBestOaLocation W18611193251 @default.
• W1861119325 hasConcept C126322002 @default.
• W1861119325 hasConcept C177713679 @default.
• W1861119325 hasConcept C2779548794 @default.
• W1861119325 hasConcept C2780161414 @default.
• W1861119325 hasConcept C2780651595 @default.
• W1861119325 hasConcept C2909938017 @default.
• W1861119325 hasConcept C2991842025 @default.
• W1861119325 hasConcept C71924100 @default.
• W1861119325 hasConcept C86803240 @default.
• W1861119325 hasConcept C89423630 @default.
• W1861119325 hasConceptScore W1861119325C126322002 @default.
• W1861119325 hasConceptScore W1861119325C177713679 @default.
• W1861119325 hasConceptScore W1861119325C2779548794 @default.
• W1861119325 hasConceptScore W1861119325C2780161414 @default.
• W1861119325 hasConceptScore W1861119325C2780651595 @default.
• W1861119325 hasConceptScore W1861119325C2909938017 @default.
• W1861119325 hasConceptScore W1861119325C2991842025 @default.
• W1861119325 hasConceptScore W1861119325C71924100 @default.
• W1861119325 hasConceptScore W1861119325C86803240 @default.
• W1861119325 hasConceptScore W1861119325C89423630 @default.
• W1861119325 hasIssue "11" @default.
• W1861119325 hasLocation W18611193251 @default.
• W1861119325 hasOpenAccess W1861119325 @default.
• W1861119325 hasPrimaryLocation W18611193251 @default.
• W1861119325 hasRelatedWork W1861119325 @default.
• W1861119325 hasRelatedWork W1981908637 @default.
• W1861119325 hasRelatedWork W1996373872 @default.

• next